Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Torras

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|July 25, 2003
Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 yearsJosep M Grinyó, Salvador Gil-Vernet, Josep M Cruzado, et al.
Journal of Clinical Medicine|August 26, 2022
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry DiseaseMarkus Cybulla, Kathleen Nicholls, Sandro Feriozzi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 8, 2011
Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantationOriol Bestard, Linda Cassis, Josep M Cruzado, et al.
International Journal of Molecular Sciences|August 12, 2022
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice ModelsJordi Guiteras, Elena Crespo, Pere Fontova, et al.
Clinical Kidney Journal|December 7, 2019
Clinical features and outcomes in a cohort of patients with immunoglobulin G4-related disease at a university hospital in SpainMaria Quero, Juliana Draibe, Xavier Solanich, et al.
Journal of Inflammation (London, England)|January 1, 2020
The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE <sup></sup> miceMiguel Hueso, Angela Casas, Adrian Mallén, et al.
Frontiers in Immunology|May 13, 2022
The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory ActivityInmaculada Serrano, Ana Luque, Francesca Mitjavila, et al.
Journal of the American Society of Nephrology : JASN|April 7, 2006
Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in ratsNúria Lloberas, Josep M Cruzado, Marcella Franquesa, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2008
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allograftsOriol Bestard, Josep M Cruzado, Inés Rama, et al.
The American Journal of Pathology|January 1, 2003
Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?Immaculada Herrero-Fresneda, Joan Torras, Josep M Cruzado, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Transplant International : Official Journal of the European Society for Organ Transplantation|July 25, 2003
Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 yearsJosep M Grinyó, Salvador Gil-Vernet, Josep M Cruzado, et al.
Journal of Clinical Medicine|August 26, 2022
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry DiseaseMarkus Cybulla, Kathleen Nicholls, Sandro Feriozzi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 8, 2011
Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantationOriol Bestard, Linda Cassis, Josep M Cruzado, et al.
International Journal of Molecular Sciences|August 12, 2022
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice ModelsJordi Guiteras, Elena Crespo, Pere Fontova, et al.
Clinical Kidney Journal|December 7, 2019
Clinical features and outcomes in a cohort of patients with immunoglobulin G4-related disease at a university hospital in SpainMaria Quero, Juliana Draibe, Xavier Solanich, et al.
Journal of Inflammation (London, England)|January 1, 2020
The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE <sup></sup> miceMiguel Hueso, Angela Casas, Adrian Mallén, et al.
Frontiers in Immunology|May 13, 2022
The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory ActivityInmaculada Serrano, Ana Luque, Francesca Mitjavila, et al.
Journal of the American Society of Nephrology : JASN|April 7, 2006
Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in ratsNúria Lloberas, Josep M Cruzado, Marcella Franquesa, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2008
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allograftsOriol Bestard, Josep M Cruzado, Inés Rama, et al.
The American Journal of Pathology|January 1, 2003
Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?Immaculada Herrero-Fresneda, Joan Torras, Josep M Cruzado, et al.
Pageof 11